Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder

被引：20

作者：

Agrawal, Manish ^{[1
]}

Emanuel, Ezekiel ^{[2
,3
]}

Richards, Brian ^{[1
,4
]}

Richards, William ^{[1
,4
]}

Roddy, Kim ^{[1
]}

Thambi, Paul ^{[1
,4
]}

机构：

[1] Sunstone Therapies, 9905 Med Ctr Dr,Suite 300, Rockville, MD 20850 USA

[2] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA USA

[3] Univ Penn, Wharton Sch, Dept Healthcare Management, Philadelphia, PA USA

[4] Maryland Oncol Hematol, Aquilino Canc Ctr, Rockville, MD USA

来源：

JAMA ONCOLOGY | 2023年 / 9卷 / 06期

关键词：

ANXIETY; LIFE;

D O I：

10.1001/jamaoncol.2023.0351

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.

引用

页码：864 / 866

页数：3

共 6 条

[1] Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer [J].

Arrieta, Oscar ;

Angulo, Laura P. ;

Nunez-Valencia, Carolina ;

Dorantes-Gallareta, Yuzmiren ;

Macedo, Eleazar O. ;

Martinez-Lopez, Dulce ;

Alvarado, Salvador ;

Corona-Cruz, Jose-Francisco ;

Onate-Ocana, Luis F. .

ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) :1941-1948

[2] The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder [J].

Brown, E. Sherwood ;

Murray, Michelle ;

Carmody, Thomas J. ;

Kennard, Beth D. ;

Hughes, Carroll W. ;

Khan, David A. ;

Rush, A. John .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (05) :433-438

[3] Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review [J].

Grassi, Luigi ;

Caruso, Rosangela ;

Hammelef, Karen ;

Nanni, Maria Giulia ;

Riba, Michelle .

INTERNATIONAL REVIEW OF PSYCHIATRY, 2014, 26 (01) :44-62

[4] Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial [J].

Griffiths, Roland R. ;

Johnson, Matthew W. ;

Carducci, Michael A. ;

Umbricht, Annie ;

Richards, William A. ;

Richards, Brian D. ;

Cosimano, Mary P. ;

Klinedinst, Margaret A. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (12) :1181-1197

[5] Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies [J].

Mitchell, Alex J. ;

Chan, Melissa ;

Bhatti, Henna ;

Halton, Marie ;

Grassi, Luigi ;

Johansen, Christoffer ;

Meader, Nicholas .

LANCET ONCOLOGY, 2011, 12 (02) :160-174

[6] The Maudsley 3-item Visual Analogue Scale (M3VAS): Validation of a scale measuring core symptoms of depression [J].

Moulton, Calum D. ;

Strawbridge, Rebecca ;

Tsapekos, Dimosthenis ;

Oprea, Emanuella ;

Ben Carter ;

Hayes, Chloe ;

Cleare, Anthony J. ;

Marwood, Lindsey ;

Mantingh, Tim ;

Young, Allan H. .

JOURNAL OF AFFECTIVE DISORDERS, 2021, 282 :280-283

← 1 →